Home  »  News   »  SMMT’s Stock Market Odyssey: A Year of Growt...

SMMT’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience

The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. Year to date metric has recorded a loss of -62.59%.However, over the last six months, we can see a weaker performance of 60.51%. Over the last 30 days, the price of SMMT has fallen by 1.27%. And in the last five days, it has fallen by -13.11%.

Summit Therapeutics Inc. (SMMT) currently has a stock price of $1.59. The stock saw a sharp increase in the last trading session, hitting a high of $1.72 after opening at $1.67. The lowest recorded price for the day was $1.57 before it closed at $1.68.

Unlock the Hottest Top 10 Penny Stocks Today! Discover Now

Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.

Gain Access to Top 10 Penny Stocks Now!.


Summit Therapeutics Inc.’s stock market performance has been consistent. The 1-year high for the company’s stock was recorded at $5.78 on 01/04/23, with the lowest value being $0.66 on 12/02/22.

52-week price history of SMMT Stock

A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. Summit Therapeutics Inc.’s current trading price is -72.49% away from its 52-week high, while its distance from the 52-week low is 140.91%. The stock’s price range over this timeframe has been between $0.66 and $5.78. The shares of the Healthcare sector company recorded a trading volume of approximately 1.49 million for the day, which was comparatively lower than the average daily volume of 2.13 million over the last three months.

The Connection Between Financial Performance and Market Capitalization

Summit Therapeutics Inc. (SMMT) has experienced a quarterly decline of -29.96% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.07B and boasts a workforce of 76 employees.

How Moving Averages and Trading Volume Data Work Together

Based on Barchart.com data, the company’s moving average over the 100-day period was 2.4088, with a change in price of -2.4100. Similarly, Summit Therapeutics Inc. recorded 2,619,474 in trading volume during the last 100 days, posting a change of -60.25%.

SMMT’s Debt-to-Equity Ratio: A Comprehensive Review

A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for SMMT stands at 4.06. Similarly, the long-term debt-to-equity ratio is also 3.90.

SMMT Stock Stochastic Average

The raw stochastic average for Summit Therapeutics Inc. over the last 50 days is presently at 30.53%. This reflects a surge from the raw stochastic average of the previous 20 days, which was noted at 30.53%. Further, the company’s Stochastic %K and %D values for the last 20 days were 34.74% and 35.44%, respectively.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts